» Articles » PMID: 7559585

Mutational Analysis of PC1 (SPC3) in PC12 Cells. 66-kDa PC1 is Fully Functional

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Oct 20
PMID 7559585
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The proteinase mPC1, a neuroendocrine member of the mammalian family of subtilisin-like enzymes, has previously been shown to be converted to a carboxyl-terminally truncated 66-kDa form during transport through the secretory pathway. The cleavage site and the function of this carboxyl-terminal truncation event are unknown. We have performed site-directed mutagenesis of two paried basic sites in the mPC1 carboxyl-terminal tail and expressed these constructs in PC12 cells, a rat pheochromocytoma known to lack endogenous PC1. We found that the most likely site for the truncation event was at Arg590-Arg591 since mutation of this site to Lys-His prevented processing of 87-kDa PC1. A PC1 mutant carboxyl-terminally truncated at this site and expressed in PC12 cells was efficiently routed to the secretory pathway and stored in secretory granules, indicating that the carboxyl-terminal extension is not required for sorting of this enzyme. The function of the various PC1 constructs was assessed by analyzing proneurotensin cleavage to various forms. The carboxyl-terminally truncated PC1 mutant was found to perform most of the cleavages of this precursor as well as wild-type PC1; however, the blockade mutant processed proneurotensin much less efficiently. Differences between the site preferences of the various enzymes were noted. Our results support the notion that carboxyl-terminal processing of PC1 serves to regulate PC1 activity.

Citing Articles

Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph.

Blanco E, Peinado J, Martin M, Lindberg I Endocrinology. 2014; 155(9):3434-47.

PMID: 24932808 PMC: 4138575. DOI: 10.1210/en.2013-2151.


Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function.

Prabhu Y, Blanco E, Liu M, Peinado J, Wheeler M, Gekakis N Endocrinology. 2014; 155(7):2391-401.

PMID: 24828610 PMC: 4060179. DOI: 10.1210/en.2013-1985.


Functional consequences of a novel variant of PCSK1.

Pickett L, Yourshaw M, Albornoz V, Chen Z, Solorzano-Vargas R, Nelson S PLoS One. 2013; 8(1):e55065.

PMID: 23383060 PMC: 3557230. DOI: 10.1371/journal.pone.0055065.


Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity.

Creemers J, Choquet H, Stijnen P, Vatin V, Pigeyre M, Beckers S Diabetes. 2012; 61(2):383-90.

PMID: 22210313 PMC: 3266396. DOI: 10.2337/db11-0305.


Hysteretic behavior of proprotein convertase 1/3 (PC1/3).

Icimoto M, Barros N, Ferreira J, Marcondes M, Andrade D, Machado M PLoS One. 2011; 6(9):e24545.

PMID: 21935423 PMC: 3174183. DOI: 10.1371/journal.pone.0024545.